10
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8506 | THPP-1 | PDE | |
THPP-1 is a potent and orally bioavailable inhibitor of PDE10A(Ki of 1 nM and 1.3 nM for human and rat PDE10A, respectively). | |||
T10822 | Cirsimarin | Cirsitakaoside | Adenosine Receptor |
Cirsimarin (Cirsitakaoside) is a flavonoid isolated from Microtea debilis. It shows a potent antilipogenic effect and decreases adipose tissue deposition in mice. Cirsimarin has antagonist activity on the adenosine A1 re... | |||
TQ0119 | Cirsimaritin | GABA Receptor | |
Cirsimaritin exhibits antibacterial, anti-inflammation, anti-tumor, antioxidant properties and renal protection. Cirsimaritin binds weakly to the benzodiazepine site on GABAA receptors. | |||
T4691 | Asimadoline hydrochloride | EMD-61753 hydrochloride | Opioid Receptor |
Asimadoline hydrochloride (EMD-61753 hydrochloride) is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline hydrochloride has also been shown to be used in the treatment of irritable bowel s... | |||
T19739 | Simazine | Tafazine,Aquazine,Radocon,Herbex | Others |
Simazine (Tafazine) is a chlorotriazine herbicide and pesticide. Simazine may lead to testicular degeneration, neuroendocrine disruption, mammary cancer, and fetal developmental delays. | |||
T124983 | Brosimacutin G | ||
Brosimacutin G is a useful organic compound for research related to life sciences and the catalog number is T124983. | |||
T80575 | Simaravibart | MAD-0004J08 | SARS-CoV |
Simaravibart (MAD-0004J08), an IgG1κ monoclonal antibody, specifically targets the receptor-binding domain of the SARS-CoV-2 spike (S) glycoprotein [1]. | |||
T34643 | Simaomicin alpha | L D42067alpha,LL D42067alpha,LL-D42067alpha | |
Simaomicin alpha is an actinomycete metabolite isolated from an actinomycete strain. | |||
T81896 | Lysimachigenoside C | ||
Lysimachigenoside C, a triterpene saponin, has been isolated from the plant Lysimachia foenum-graecum Hance [1]. | |||
T4633 | Asimadoline | EMD-61753 | Opioid Receptor |
Asimadoline (EMD-61753) is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline... |